BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7981226)

  • 1. Substrate specificity of porcine renin: P1', P1, and P3 residues of renin substrates are crucial for activity.
    Wang W; Liang TC
    Biochemistry; 1994 Dec; 33(48):14636-41. PubMed ID: 7981226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.
    Tözsér J; Weber IT; Gustchina A; Bláha I; Copeland TD; Louis JM; Oroszlan S
    Biochemistry; 1992 May; 31(20):4793-800. PubMed ID: 1591240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate.
    Chang JY
    Eur J Biochem; 1985 Sep; 151(2):217-24. PubMed ID: 2863141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the P1' specificity of the matrix metalloproteinases: effect of S1' pocket mutations in matrilysin and stromelysin-1.
    Welch AR; Holman CM; Huber M; Brenner MC; Browner MF; Van Wart HE
    Biochemistry; 1996 Aug; 35(31):10103-9. PubMed ID: 8756473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the P1', P2' and P3' subsite-specificity of factor Xa.
    Ludeman JP; Pike RN; Bromfield KM; Duggan PJ; Cianci J; Le Bonniec B; Whisstock JC; Bottomley SP
    Int J Biochem Cell Biol; 2003 Feb; 35(2):221-5. PubMed ID: 12479872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL
    Cesar Ramos de Jesus H; Solis N; Machado Y; Pablos I; Bell PA; Kappelhoff R; Grin PM; Sorgi CA; Butler GS; Overall CM
    J Virol; 2024 Jun; 98(6):e0004924. PubMed ID: 38742901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificity of the Escherichia coli outer membrane protease OmpT.
    McCarter JD; Stephens D; Shoemaker K; Rosenberg S; Kirsch JF; Georgiou G
    J Bacteriol; 2004 Sep; 186(17):5919-25. PubMed ID: 15317797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity of beta-collagenase from Clostridium histolyticum.
    Steinbrink DR; Bond MD; Van Wart HE
    J Biol Chem; 1985 Mar; 260(5):2771-6. PubMed ID: 2982835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
    Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
    Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent oligopeptide substrates for kinetic characterization of the specificity of Astacus protease.
    Stöcker W; Ng M; Auld DS
    Biochemistry; 1990 Nov; 29(45):10418-25. PubMed ID: 2261483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
    Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W
    Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of lysine 60f to S1' specificity of thrombin.
    Rezaie AR; Olson ST
    Biochemistry; 1997 Feb; 36(5):1026-33. PubMed ID: 9033392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate specificities and kinetic properties of proteinase A from the yeast Saccharomyces cerevisiae and the development of a novel substrate.
    Kondo H; Shibano Y; Amachi T; Cronin N; Oda K; Dunn BM
    J Biochem; 1998 Jul; 124(1):141-7. PubMed ID: 9644256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended substrate specificity of rat mast cell protease 5, a rodent alpha-chymase with elastase-like primary specificity.
    Karlson U; Pejler G; Tomasini-Johansson B; Hellman L
    J Biol Chem; 2003 Oct; 278(41):39625-31. PubMed ID: 12900423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26.
    Park HI; Turk BE; Gerkema FE; Cantley LC; Sang QX
    J Biol Chem; 2002 Sep; 277(38):35168-75. PubMed ID: 12119297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the P1' substrate specificities of pepsin A and chymosin.
    Kageyama H; Ueda H; Tezuka T; Ogasawara A; Narita Y; Kageyama T; Ichinose M
    J Biochem; 2010 Feb; 147(2):167-74. PubMed ID: 19819898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential elevation of exopeptidase activity of Glu-specific endopeptidase I/GluV8 mediated by hydrophobic P1'-position amino acid residue.
    Nemoto TK; Nishimata H; Shirakura K; Ohara-Nemoto Y
    Biochimie; 2024 May; 220():99-106. PubMed ID: 38159715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.
    Reichelt A; Gaul C; Frey RR; Kennedy A; Martin SF
    J Org Chem; 2002 Jun; 67(12):4062-75. PubMed ID: 12054939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.